Dcm Shriram International Ltd vs Skybiotech Healthcare Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 28, 2026

Key Highlights

The Latest Trading Price of DCM Shriram International Ltd is ₹ 71.7 as of 25 Jun 15:30 . The P/E Ratio of DCM Shriram International Ltd is 0 as of March 2025 .The P/E Ratio of Skybiotech Healthcare Limited is 0 as of March 2025 . The Market Cap of DCM Shriram International Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Skybiotech Healthcare Limited is ₹ 31.33 crore as of March 2025 . The revenue of DCM Shriram International Ltd for the Mar '26 is ₹ 121.22 crore as compare to the Dec '25 revenue of ₹ 121.29 crore. This represent the decline of -0.06% The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore. This represent the growth of 90.38% The ebitda of DCM Shriram International Ltd for the Mar '26 is ₹ -12.08 crore as compare to the Dec '25 ebitda of ₹ 10.44 crore. This represent the decline of -215% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore. This represent the growth of 102.78% The net profit of DCM Shriram International Ltd changed from ₹ 15.3 crore to ₹ -18.22 crore over 6 quarters. This represents a CAGR of NaN% The net profit of Skybiotech Healthcare Limited changed from ₹ 0.25 crore to ₹ -0.3 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of DCM Shriram International Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Skybiotech Healthcare Limited changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About DCM Shriram International Ltd

DCM Shriram International Limited was incorporated as a Public limited company and a Certificate of Incorporation dated September 07, 2022 was issued by the Registrar of Companies, Central Registration Centre, Manesar.
The Company is engaged in business of Rayon, Nylon, Nylon Tyre cord, fabrics and industrial yarns etc. Prior to the Demerger, Company was a wholly owned subsidiary of DCM Shriram Industries Limited.
The main object of the Company is to carry on the business of design, development, manufacturing and sale of commercial vehicles.
Pursuant to the Scheme becoming effective on 17th December, 2025, the Rayon Business of DCM Shriram Industries Limited has been demerged into the Company with effect from April 1, 2023. In terms of the said Scheme, 8,69,92,185 Equity Shares of Rs 2 each fully paid up have been allotted to the shareholders of DCM Shriram Industries Limited on 26 December, 2025.

About Skybiotech Healthcare Limited

Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for the comparison of DCM Shriram International Ltd and Skybiotech Healthcare Limited

Which company has a larger market capitalization, DCM Shriram International Ltd or Skybiotech Healthcare Limited?

Market cap of DCM Shriram International Ltd is 623 Cr while Market cap of Skybiotech Healthcare Limited is 38 Cr

What are the key factors driving the stock performance of DCM Shriram International Ltd and Skybiotech Healthcare Limited?

The stock performance of DCM Shriram International Ltd and Skybiotech Healthcare Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for DCM Shriram International Ltd and Skybiotech Healthcare Limited?

As of June 28, 2026, the DCM Shriram International Ltd stock price is INR ₹71.7. On the other hand, Skybiotech Healthcare Limited stock price is INR ₹199.95.

How do dividend payouts of DCM Shriram International Ltd and Skybiotech Healthcare Limited compare?

To compare the dividend payouts of DCM Shriram International Ltd and Skybiotech Healthcare Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.